Showing results (571-580 of 639) with videos related to

Sort By:
Pageof 64
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 3, 2021
Evidence of enteric angiopathy and neuromuscular hypoxia in patients with mitochondrial neurogastrointestinal encephalomyopathyElisa Boschetti, Roberto D'Angelo, Maria Lucia Tardio, et al.
Frontiers in Immunology|June 4, 2026
The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemiaAlessandro Bruno, Francesca Lorentino, Matteo G Carrabba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2015
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem CellsNicoletta Cieri, Raffaella Greco, Lara Crucitti, et al.
Therapeutic Advances in Infectious Disease|October 1, 2024
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipientsFrancesca Farina, Andrea Acerbis, Chiara Oltolini, et al.
Frontiers in Immunology|February 13, 2023
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boostersMaria Rescigno, Chiara Agrati, Carlo Salvarani, et al.
Therapeutic Advances in Hematology|June 24, 2022
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donorsCarmine Liberatore, Maria Teresa Lupo Stanghellini, Francesca Lorentino, et al.
Current Research in Translational Medicine|June 18, 2023
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experienceEdoardo Campodonico, Elisabetta Xue, Simona Piemontese, et al.
Leukemia|November 6, 2014
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantationL Crucitti, R Crocchiolo, C Toffalori, et al.
Transplantation and Cellular Therapy|June 4, 2021
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell TransplantRaffaella Greco, Francesca Lorentino, Serena Albanese, et al.
Neurogastroenterology and Motility|April 13, 2018
INPP4B overexpression and c-KIT downregulation in human achalasiaE Bonora, F Bianco, A Stanzani, et al.
Pageof 64